Checkpoint Capital L.P. - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Checkpoint Capital L.P. held in its portfolio 6 assets valued at $320,095,902 (i.e. $320.10M).

The most valuable assets in the portfolio included: ARGENX SE ($119.42M), RHYTHM PHARMACEUTICALS INC ($106.21M), and DISC MEDICINE INC ($35.97M).

The chart below shows the top 6 valuable assets, and the table below shows the top 6 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Checkpoint Capital L.P. Portfolio

ARGENX SE

RHYTHM PHARMACEUTICALS INC

DISC MEDICINE INC

REVOLUTION MEDICINES INC

CORCEPT THERAPEUTICS INC

CYTOKINETICS INC

Checkpoint Capital L.P. - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ARGENX SE	142000	119414900	SPONSORED ADR
RHYTHM PHARMACEUTICALS INC	992200	106205088	COM
DISC MEDICINE INC	452992	35972095	COM
REVOLUTION MEDICINES INC	370000	29470500	COM
CORCEPT THERAPEUTICS INC	529695	18433386	COM
CYTOKINETICS INC	166823	10599933	COM NEW